Robert C. Lanman
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pharmacogenetics and Drug Metabolism 8
-
- Drug Solubulity and Delivery Systems 5
- Advanced Drug Delivery Systems 2
- Co-authors
- Lewis S. Schanker (8 shared papers)Scott James Weir (4 shared papers)Dale K. Yu (4 shared papers)Vijay O. Bhargava (2 shared papers)Dennis H. Giesing (4 shared papers)Thomas M. Ludden (2 shared papers)Z Fuks (1 shared paper)Edward B. Kirsten (2 shared papers)
- Journals
- Journal of Pharmaceutical Sciences (3 papers)Biopharmaceutics & Drug Disposition (3 papers)Life Sciences (2 papers)Analytical Letters (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
- Partner nations
- United StatesAustriaChina
In The Last Decade
Robert C. Lanman
22 papers receiving 328 citations
Peers
Comparison fields: 5 of 55
- Pharmaceutical Science 67
- Pharmacology 88
- Pharmacology 48
- Neurology 21
- Toxicology 10
Countries citing papers authored by Robert C. Lanman
This map shows the geographic impact of Robert C. Lanman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert C. Lanman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert C. Lanman more than expected).
Fields of papers citing papers by Robert C. Lanman
This network shows the impact of papers produced by Robert C. Lanman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert C. Lanman. The network helps show where Robert C. Lanman may publish in the future.
Co-authors
The 16 scholars most cited alongside Robert C. Lanman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 39 | |
| 2 | 1987 | 38 | |
| 3 | 1990 | 31 | |
| 4 | 1980 | 30 | |
| 5 | 1971 | 29 | |
| 6 | 1973 | 26 | |
| 7 | 1976 | 26 | |
| 8 | 1964 | 23 | |
| 9 | 1995 | 23 | |
| 10 | 1987 | 20 | |
| 11 | 1995 | 19 | |
| 12 | 1971 | 15 | |
| 13 | 1986 | 14 | |
| 14 | 1995 | 11 | |
| 15 | 1998 | 11 | |
| 16 | 1970 | 8 | |
| 17 | 1980 | 8 | |
| 18 | 1980 | 8 | |
| 19 | 1991 | 6 | |
| 20 | 1973 | 5 |
About Robert C. Lanman
Robert C. Lanman is a scholar working on Pharmacology, Pharmaceutical Science, Analytical Chemistry, Oncology and Cellular and Molecular Neuroscience, having authored 23 papers that have together received 400 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Drug Solubulity and Delivery Systems (5 papers), Analytical Methods in Pharmaceuticals (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Inflammatory Bowel Disease (2 papers), Advanced Drug Delivery Systems (2 papers), Ion Transport and Channel Regulation (2 papers) and Receptor Mechanisms and Signaling (1 paper). The work is most often cited by research in Pharmaceutical Science (67 citations), Pharmacology (88 citations), Pharmacology (48 citations), Neurology (21 citations) and Toxicology (10 citations). Robert C. Lanman has collaborated with scholars based in United States, Austria and China. Frequent co-authors include Lewis S. Schanker, Scott James Weir, Dale K. Yu, Vijay O. Bhargava, Dennis H. Giesing, Thomas M. Ludden, Z Fuks, Edward B. Kirsten, Greg C. G. Wei and William D. Mason. Their work appears in journals such as Journal of Pharmaceutical Sciences, Biopharmaceutics & Drug Disposition, Life Sciences, Analytical Letters and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.